Samuel Gidding Siris MD
Psychopharmacology
Adjunct Professor, Psychiatry & Behavioral Sciences, Albert Einstein College of Medicine
Join to View Full Profile
7559 263rd StGlen Oaks, NY 11004
Phone+1 718-470-8138
Fax+1 718-831-0368
Dr. Siris is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric InstituteResidency, Psychiatry, 1971 - 1974
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalInternship, Internal Medicine, 1970 - 1971
Columbia University Vagelos College of Physicians and SurgeonsClass of 1970
Certifications & Licensure
NY State Medical License 1971 - 2019
NJ State Medical License 1972 - 2015
American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 1 citationsIntegrating Social Determinants of Health Into Clinical Formulations: The Need for a Biaxial System in theand Psychiatry.Matthew D Erlich, Michael B First, Rachel M Talley, Lisa B Dixon, Jeffrey Berlant
Psychiatric Services. 2025-10-01 - 13 citationsAddressing the Increasing Mental Health Distress and Mental Illness Among Young Adults in the United States.Mary F Brunette, Matthew D Erlich, Matthew L Edwards, David A Adler, Jeffrey Berlant
The Journal of Nervous and Mental Disease. 2023-12-01 - 2 citationsPsychiatry in the Time of COVID: Credibility, Uncertainty, and Self-Reflection.David A. Adler, Matthew D. Erlich, Beth Goldman, Jeffrey Berlant, Matthew L. Edwards
The Journal of Nervous and Mental Disease. 2021-11-01
Grant Support
- Antidepressant For Drug-Abusing Dysphoric SchizophrenicsNational Institute On Drug Abuse1988–1989
- Adjunctive I Mipramine In "Depressed" SchizophrenicsNational Institute Of Mental Health1988
- Antidepressant For Drug-Abusing Dysphoric SchizophrenicsNational Institute On Drug Abuse1987
- Adjunctive I Mipramine In "Depressed" SchizophrenicsNational Institute Of Mental Health1987
- Adjunctive Imipramine In Depressed SchizophrenicsNational Institute Of Mental Health1985–1986
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
